Institution - Queen Mary University of London
Researcher - Dr Gunnel Hallden
Grant award - £99,996
Duration - 2013-2016
Reference - S12-021

In a nutshell

This project will further investigate the safety, specificity and action of a virus that kills cancer cells in advanced prostate cancer.  Initial results suggest that this virus improves treatment of advanced prostate cancer when applied together with conventional chemotherapy.

Why we funded it

This project proposes a new way to treat advanced metastatic prostate cancer (prostate cancer that has spread to other sites in the body). The scientists aim to exploit the fact that cancer cells grow and divide much faster than normal cells. They have artificially altered a virus so that it cannot cause disease but instead enters dividing cancer cells and kills them.  The scientists hope that using this virus at the same time as conventional chemotherapy will make treatment for advanced prostate cancer more effective.

Download digital versions of this research summary